## Background and objective: The 1,450-nm smoothbeam laser is a diode laser equipped with a cryogen cooling spray. primary objectives were to evaluate the effects of this non-ablative laser on apligraf (bioengineered skin-substitute) and to document its use as a model for non-ablative procedures. w
Non-ablative 1,450-nm diode laser treatment of striae distensae
β Scribed by Yong-Kwang Tay; Colin Kwok; Eileen Tan
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 158 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
β¦ Synopsis
Background and Objectives: Striae distensae are dermal scars with flattening and atrophy of the epidermis. Successful treatment of these stretch marks has been disappointing. The non-ablative 1,450-nm diode laser has been shown to improve atrophic scars and may be expected to improve striae. As yet, no study has been published to document the effects of this laser on striae. Our aim is to evaluate the efficacy of the 1,450-nm diode laser in the treatment of striae rubra and striae alba in Asian patients with skin types 4-6. Study Design/Materials and Methods: Striae on one half of the body in 11 patients were treated with the 1,450-nm diode laser with cryogen cooling spray with the other half serving as a control. The following parameters were used: 6 mm spot size and dynamic cooling device (DCD) for 40 milliseconds to protect the epidermis. Patients were randomly assigned to receive either 4, 8, or 12 J/cm 2 . A total of three treatments were given at 6-week intervals. The following sites were treated: abdomen, arms, back, buttocks, and thighs. Two patients had striae rubra and nine striae alba. Clinical photographs were taken before and after each treatment and analysis was undertaken through photographic evaluation by non-treating physicians. Results: At 2 months after the last treatment, no patients showed any noticeable improvement in the striae on the treated side compared to baseline and to the control areas. Side effects were limited to transient erythema and postinflammatory hyperpigmentation (PIH), which occurred in seven (64%) patients. Conclusions: The non-ablative 1,450-nm diode laser is not useful in the treatment of striae in patients with skin types 4, 5, and 6.
π SIMILAR VOLUMES
## Background and objectives: The 585-nm pulsed-dye laser and the 1,450-nm diode laser have been found effective for the treatment of mild-to-moderate inflammatory facial acne. this study was designed to evaluate the efficacy and safety of the combined treatment with the 595-nm pulsed-dye laser and
## Abstract ## Background and Objective Nonβablative dermal remodeling has been shown to create new dermal collagen. This is thought to occur secondary to a laserβinduced injury to the skin. Other mechanisms of injury may lead to similar results. The aim of this study was to evaluate the efficacy
## Abstract ## Background and Objective Laser therapy with a 1,450 nm diode laser is a clinically effective treatment for acne vulgaris, although the mechanism of action is unknown. To investigate this, we conducted a small, prospective, controlled clinical trial to assess this laser's effects on
Background and Objective: Nonablative resurfacing has proven its efficacy in vascular and pigmented lesions, while its capacity of substantial wrinkle reduction is still discussed controversially. We present the treatment results of a 1,450 nm diode laser for facial rhytides. Methods: Thirty facial
## Abstract ## Background and Objectives Over the last several years, several lightβbased systems have been employed for the treatment of acne vulgaris. The 1,450βnm diode laser has been shown to improve acne, and this has been suggested to be due to effects on sebaceous glands. However, an effect